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http://dx.doi.org/10.1016/j.asjsur.20Summary Objective: The purpose of this study was to investigate the expression of glial cell
derived neurotrophic factor (GDNF), glypican-1 (GPC-1), and matrix metalloproteinase-9
(MMP-9), and their association with clinicopathologic characteristics as well as prognostic
significance in pancreatic cancer.
Methods: Immunohistochemical assessment of GDNF, GPC-1, and MMP-9 was performed in 62
cases of surgically resected pancreatic cancer. Perineural invasion in pancreatic cancer was
observed by marking nerve fiber with S-100, while 16 normal pancreatic tissues were used
as normal control. Correlations of GDNF, GPC-1 and MMP-9 expressions with clinicopathologic
parameters were analyzed. A survival analysis was performed to find the prognostic signifi-
cance.
Results: The expressions of GDNF, GPC-1 and MMP-9 in pancreatic cancer tissue were signifi-
cantly higher than of those in normal pancreatic tissues (41/62 vs. 5/16 for GDNF, 35/62 vs.
2/16 for GPC-1, and 37/62 vs. 3/16 for MMP-9; p< 0.01, respectively). The overexpression
of GDNF, GPC-1, and MMP-9 in pancreatic cancer tissue was significantly related to the peri-
neural invasion (p< 0.05). Although the overexpression of these genes was related to poor
survival, GPC-1 had an independent prognostic effect on overall survival.
Conclusion: GPC-1 is significantly related to the perineural invasion of pancreatic cancer,
holding some prognostic significance in patients with pancreatic cancer.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.t of Biliopancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008,
(G.-h. Hu).
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8 L. Duan et al.1. Introduction
mous according to the ethical and legal standards.Globally, pancreatic cancer is equivalent to 2.5% of all
types of cancer. However, because of its high mortality, it
ranks as the fourth or fifth most frequent cause of cancer
death in most developed countries.1 The mortality of
pancreatic cancer is also equivalent to its incidence per
year.1,2 This high mortality is mainly attributed to local
invasion and distant metastasis.3 Perineural invasion (PNI)
is one of the most important modes of invasion, which
happens even in the early stage.4 It limits radical resection
and promotes local recurrence, which negatively impacts
survival time and life quality of the patients with pancre-
atic cancer.5 In spite of this, the mechanism of PNI remains
unknown. Although research interests have covered a wide
range of genetic and epigenetic alterations, recent
research6e8 has focused on the roles of glial cell line-
derived neurotrophic factor (GDNF), glypican-1 (GPC-1),
and matrix metalloproteinase-9 (MMP-9); this is because all
of them are highly expressed in various carcinomas,
promoting tumor invasion and metastasis. However, little is
known about their involvement in PNI in pancreatic cancer.
GDNF belongs to the transforming growth factor (TGF)-
b superfamily, which is known as HBGFs after combining
with heparan.6 GPC-1 can regulate the combination of
HBGFs with their high-affinity receptors and enhance tumor
growth and invasion.9,10 Okada et al. have revealed that
GDNF increases MMP-9 mRNA and protein expression in MIA
PaCa-2 cells in a dose-dependent manner.11 Koyama et al12
have showed that the interaction of GPC-1 heparan
sulphate chains with MMP-9 on the cell surface is crucial for
the migration and invasion of the murine colon adenocar-
cinoma cells. All these findings suggest some correlation
between these factors, yet the key factor to the pancreatic
cancer invasion is not known. In the current study, the
protein expressions of GDNF, GPC-1, and MMP-9 in pancre-
atic cancer tissue were investigated, and a correlative
analysis of the three factors with the clinical features and
survival time of the patients was performed to find out
what was the most significant factor among them.2. Materials and methods2.1. Patients and tissue sampling
The specimens of pancreatic cancer tissues were taken
from 62 patients who underwent radical excision for
pancreatic ductal adenocarcinoma between January 2003
and December 2010 at the Department of General Surgery,
Xiangya Hospital, Central South University (Changsha,
China). All the specimens were ductal adenocarcinoma,
and the diagnosis was confirmed by two pathologists at our
hospital. Another 16 pancreatic specimens were obtained
from the patients of pancreatic injury as normal control
samples for the tests. The samples were fixed in 10%
formalin immediately after being taken from the patients.
A prior informed consent was obtained from the patients
for the specimen collection, and the study protocols were
approved by the Ethics Committee of Central SouthUniversity. All specimens were handled and made anony-
The specimens were fixed with 10% formalin, routinely
processed for embedding in paraffin, and cut into 4-mm
sections in five randomized choosing sites. Every site was
cut down into four pieces (used for PNI, GDNF, GPC-1, and
MMP-9 each).
For immunohistochemical analysis, the sections were
stained by streptavidin-peroxidase method with the use of
a DAB kit (mouse monoclonal, Santa Cruz Biotechnology,
United States of America). After deparaffinization and
dehydration, the sections were subjected to microwave
oven treatment in 0.01 mol/L sodium citrate buffer (pH
6.0) for 10 minutes to block endogenous peroxidase. All the
sections were then immersed in nonimmune serum (block-
ing reagent) for 5 minutes to block nonspecific
immunoglobulin-binding sites. After removal of excess
serum, primary antibodies for S-100 (rabbit polyclonal;
1:100; Santa Cruz Biotechnology), GDNF (rabbit polyclonal;
1:50; Santa Cruz Biotechnology), GPC-1 (rabbit polyclonal;
1:50; Santa Cruz Biotechnology), and MMP-9 (rabbit poly-
clonal; 1:50; Santa Cruz Biotechnology) were added to the
sections and incubated overnight at 4C. Then, the sections
were washed 2 3 minutes with phosphate buffer solution
(PBS), incubated with secondary antibody (mouse anti-
rabbit; 1:100; Santa Cruz Biotechnology) for 20 minutes,
and with streptavidin-peroxidase complex for 20 minutes.
After washing 2 3 minutes with PBS, the sections were
stained with diaminobenzidine tetrahydrochloride, freshly
prepared in trihydroxymethyl aminomethane (TRIS) buffer
containing 0.01% H2O2. Nuclei were lightly counterstained
with hematoxylin. For negative controls, the sections were
incubated with PBS instead of the primary antibody. Finally,
the sections were mounted on slides with Permount after
dehydrated in alcohol and cleared in xylene.
2.2. Evaluation of positive PNI
PNI is defined as the presence of cancer cells in the peri-
neurium.13 On every case, five sections were used for
detecting S-100, which was stained in the area of neural
fascicle and its perineurium in brown color; the cases in
which cancer cells were present in any medial perineurium
were regarded as PNI (þ). If no cancer cells were seen in
the medial perineurium of any of the five sections, then the
case was called as PNI ().
2.3. Evaluation of immunohistochemical staining
On each section, five randomly chosen fields were used for
counting both the positive cells and negative cells;
a percentage was calculated for positive cells among the
whole cells counted. Fine granular plasma and/or
membrane staining was regarded as positive. We classified
the results into four grades: (0), positive cells accounted
for less than 10%, (1) between 10% and 29%, (2) between
30% and 49%, and (3) more than 50%. The intensity of
staining was graded as: 0Z none; 1Zweak brown;
2Zmoderate brown; and 3Z strong brown. An overall
score for each sample was calculated as grade intensity.
Scores  2 was considered (þ), and scores < 2 were
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data, observed and evaluated all the slides.
2.4. Follow-up
Follow-up was either performed by interviewing the
patients in our institution on an outpatient basis or by
contacting their guardian who took care of them. The
cutoff for clinical follow up was December 31, 2011.
Survival was calculated from the date of primary resection
until the date of death from any cause for overall survival.
For patients lost to follow-up, data were censored at the
date the patient was last contacted alive.
2.5. Statistical analyses
SPSS version 13.0 for Windows (SPSS Inc, Chicago, IL, USA)
was used for the statistical analysis. Patients’ clinicopath-
ologic characteristics were compared between groups using
Chi-square or Fisher’s exact test for categorical variables.
Survival estimates were analyzed with Kaplan and Meier
survival curves by the log-rank test. Logistic regression
analysis was performed to identify variables significantly
associated with clinicopathological data. The Cox propor-
tional hazards model was used to identify variables related
to overall survival. A value of p< 0.05 was considered
statistically significant.
3. Results
3.1. Expression and localization of S-100, GDNF,
GPC-1, and MMP-9 in pancreatic tissues
Positive S-100 staining (showing in brown color) was
detected in the neural fascicle and its perineurium in
almost every section; 32 cases were PNI (þ) (32/62, 51.6%).
The cancer cells were present in medial perineurium
(Fig. 1A). General data (sex, age, tumor lymph node
metastasis (TNM) stage of the tumor, the differentiation,
location and diameter of the tumor, and lymph node
involvement) of the patients are listed in Table 2.
Immunohistochemical results are summarized in Table 1.
In normal pancreatic tissue, there were only traces of GDNF,Figure 1 The representative images of immunochemistry (counte
Positive staining of (B) GDNF, (C) GPC-1, and (D) MMP-9 in pancre
(400). GDNFZ glial cell derived neurotrophic factor; GPC-1Z glyGPC-1, and MMP-9 staining. In the pancreatic cancer tissue,
the targeted GDNF and GPC-1 were highly expressed and
mainly located in the cell membrane and cytoplasm and
MMP-9 in the cytoplasm (Figs. 1BeD). GDNF was strongly
expressed in pancreatic cancer cells and intrapancreatic
nerves. Strong GPC-1 immunoreactivity was present in the
fibroblasts surrounding the cancer cells. MMP-9 protein
expression was mainly seen in the pancreatic cancer
cells. The expression of GDNF in pancreatic cancer cases
was significantly higher than of those in normal pancre-
atic tissues (41/62, 5/16; p< 0.01), as well as the GPC-1
and MMP-9 expressions (35/62, 2/16; p< 0.01; 37/62,
3/16; p< 0.01 respectively).3.2. Relationship between the expression of GDNF,
GPC-1, MMP-9, and clinicopathologic
characteristics
The expressions of GDNF, GPC-1, and MMP-9 were signifi-
cantly linked to PNI (pZ 0.002, 0.011, 0.002; Table 2), but
not to sex, age, TNM stage, tumor location, size, degree of
differentiation, or lymph node involvement in pancreatic
cancer. The multiple logistic regression analysis showed
that GPC-1 was the most dangerous factor among the three
to predict PNI (Table 3).3.3. Survival analysis
All of the pancreatic cancer patients had been followed
2e75 months (17.2 14.2 months) until their death. There
were five patients still alive, and the median survival time
after resection was 14 months. Patient survival was asso-
ciated with PNI (Fig. 2A, log-rankZ 7.174, pZ 0.007), but
not to the sex, age, tumor location, size, degree of
differentiation, or lymph node involvement. Even though
the log-rank test (Figs. 2BeD) showed that the expression
of GDNF, GPC-1, and MMP-9 were all significantly related to
the survival rate after resection (log-rankZ 9.696,
pZ 0.002; log-rankZ 8.975, pZ 0.003; log-rankZ 3.899,
pZ 0.048; respectively), Cox regression analysis of the
above four co-variates further confirmed that only the
expression of GPC-1 was significantly related to the survival
rate after resection (Table 4).rstained with hematoxylin). (A) Nerve fibers marked by S-100.
atic cancer tissue. Brown color indicates the positive staining
pican-1; MMP-9Zmatrix metalloproteinase-9.
Table 1 Expression of GDNF, GPC-1 and MMP-9 in various
tissues.
Pancreatic
cancer (n)
Normal pancreatic
tissue (n)
() (þ) () (þ)
GDNF 21 41 11 5
GPC-1 27 35 14 2
MMP-9 25 37 13 3
GDNFZ glial cell derived neurotrophic factor; GPC-1Z glypi-
can-1; MMP-9Zmatrix metalloproteinase-9.
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The peripheral nerve system is covered by three
membranes: the endoneurium, perineurium, and epineu-
rium. PNI is defined as the presence of cancer cells in the
perineurium.13 In this study, we labeled the nerve tissue by
S-100 through immunohistochemical staining, which made
the detection of nerve tissue easier than through HE
staining, and it helped us accurately determine the infil-
tration of nerve fibers by cancer cells. Furthermore, we
stained five sections taken from different locations in eachTable 2 Relationship between the expression of GDNF, GPC-1,
Clinicopathologic characteristics NZ 62 GDN
(þ)
Sex
Men 41 30
Women 21 11
Age (yr)
<60 38 24
60 24 17
Tumor location
Head 43 28
Body-tail 19 13
Tumor maximum diameter (cm)
<2 6 4
2w5 40 25
5 16 12
TNM stage
I 11 7
II 18 14
III 33 20
Degree of tissue differentiation
High 33 21
Middle-low 29 20
Lymph node involvement
No 29 17
Yes 33 24
Perineural invasion
() 30 14
(þ) 32 27
*p< 0.05 was considered to be statistically significant, Fisher’s exact
GDNFZ glial cell derived neurotrophic factor; GPC-1Z glypican-1;
metastasis.specimen to detect PNI in pancreatic cancer. The expres-
sions of GDNF, GPC-1, and MMP-9 in pancreatic ductal
adenocarcinoma tissues were found upregulated. They
were positively related with PNI and a worse prognosis
postsurgery. Furthermore, GPC-1 was found to be the most
significant factor that was related to the degree of PNI and
a worse prognosis.
GPC-1, a ubiquitous protein that is attached to the
extracytoplasmic surface of the cell membrane, may play
a role in the control of cell division and growth.14 Multiple
signaling pathways, including the ERK MAPK and c-Myc
signaling, are stimulated by GPC-1,15 and it is overex-
pressed in pancreatic cancer cells and the adjacent fibro-
blasts.16 Down-regulation of GPC-1in the human pancreatic
cancer cell line PANC-1 leads to a prolonged doubling time,
and attenuates tumor growth, angiogenesis, and metastasis
when these cells are transplanted into athymic mice.7
GDNF, a member of the neurotrophic factor family that is
necessary for the growth, development, and reparation of
a variety of neural cell types, is found to be associated with
the pathogenesis of malignant melanoma, and it is related
to the prognosis of patients with pancreatic cancer and also
involved in squamous non-small-cell carcinoma.6,17,18 MMP-
9 is a member of the MMP family, which is involved in the
breakdown of extracellular matrix in both normalMMP-9, and clinicopathologic characteristics.
F GPC-1 MMP-9
p value (þ) p value (þ) p value
0.102 0.644 0.166
24 27
11 10
0.534 0.773 0.051
22 19
13 18
0.800 0.564 0.219
26 25
9 12
0.854 0.518 0.185
4 2
23 27
8 8
0.331 0.592 0.374
6 7
10 11
19 19
0.658 0.482 0.719
20 19
15 18
0.242 0.482 0.231
15 15
20 22
<0.001* <0.001* <0.001*
12 12
23 25
test.
MMP-9Zmatrix metalloproteinase-9; TNM Z tumor lymphnode
Table 3 Logistic regression analysis in relation to peri-
neural invasion.
Factors Odds
ratio
95% confidence
interval
p value
GDNF [() vs. (þ)] 1.424 1.264e1.604 <0.001*
GPC-1 [() vs. (þ)] 1.925 1.755e2.112 <0.001*
MMP-9 [() vs. (þ)] 1.509 1.356e1.680 <0.001*
*p< 0.05 was considered to be statistically significant.
GDNFZ glial cell derived neurotrophic factor; GPC-1Z glypi-
can-1; MMP-9Zmatrix metalloproteinase-9.
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reproduction, and tissue remodeling), and disease
processes (such as arthritis and metastasis).19 MMP-9 is also
overexpressed in pancreatic cancer and correlated with
a worse prognosis.20
Our results are basically in line with above mentioned
others findings, with slightly more features being revealed
in this study: (1) The overexpression of GPC-1, GDNF, andFigure 2 Kaplan-Meier survival curves for the four covariates in
survival time between PNI (þ) and PNI () is significantly differen
survival time between GDNF (þ) and () is significantly different
survival time between GPC-1 (þ) and () is significantly dif
covariate, survival time between MMP-9 (þ) and () is significantly
neurotrophic factor; GPC-1Z glypican-1; MMP-9Zmatrix metallopMMP-9 in pancreatic tumor tissue is linked mainly to PNI,
not to other clinical characteristics, (2) GPC-1 is the most
dangerous factor among the three in predicting PNI, and (3)
even the expression of GDNF, GPC-1, and MMP-9 would
prognose a worse survival, only the expression of GPC-1 was
significantly related to the survival rate of the patient and
it may be used as an independent prognostic factor for
pancreatic ductal adenocarcinoma. More interestingly, we
found that GPC-1 was significantly related to the survival
independent of PNI, which does not contradict our immu-
nohistochemical results, showing various aspects of the
involvement of GPC-1 in the cancer other than PNI. The
carcinogenetic role of GPC-1 in pancreatic cancer is also
further highlighted in recent studies: Whipple et al.21 have
found that pancreatic ductal adenocarcinoma growth,
angiogenesis, and invasion are enhanced by GPC-1 in
a mouse model. Furthermore, the suppression of GPC-1 is
suggested to be an important component of therapeutic
strategies in pancreatic ductal adenocarcinoma. Di Norcia
et al.22 have also found that the loss of RAGE (the receptor
for advanced glycation end-products) function inhibits thepancreatic cancer patients. (A) When PNI is the covariate, the
t (pZ 0.007, log-rank test); (B) when GDNF is the covariate,
(pZ 0.002, log-rank test); (C) when GPC-1 is the covariate,
ferent (pZ 0.003, log-rank test); (D) when MMP-9 is the
different (pZ 0.048, log-rank test). GDNFZ glial cell derived
roteinase-9; PNIZ perineural invasion.
Table 4 Cox proportional hazards model with potential
variables predicting overall survival.
Variables Odds
ratio
95% confidence
interval
p value
PNI [() vs. (þ)] 1.189 0.640e2.209 0.584
GDNF [() vs. (þ)] 1.237 0.836e1.829 0.287
GPC-1 [() vs. (þ)] 1.584 1.055e2.378 0.026*
MMP-9 [() vs. (þ)] 1.159 0.850e1.582 0.351
*p< 0.05 was considered to be statistically significant.
GDNFZ glial cell derived neurotrophic factor; GPC-1Z glypi-
can-1; MMP-9Zmatrix metalloproteinase-9; PNIZ perineural
invasion.
12 L. Duan et al.development of pancreatic intraepithelial neoplasia and its
progression to adenocarcinoma, significantly prolonging
survival time in mouse models. It is reasonable that among
these three pancreatic cancer-related genes, GPC-1 is the
one needs further investigation.
In conclusion, we have found through this study that
GPC-1 is significantly related to PNI of pancreatic cancer,
and that it is with some prognostic significance in patients
with pancreatic cancer. Further studies on the molecular
mechanisms of PNI and on the prognostic significance of
GPC-1 in pancreatic cancer will be required, which may
contribute to the establishment of effective pancreatic
cancer therapy and may lead to better management of the
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